Atlas Trials

COVID-19 Convalescent Plasma (CCP) Transfusion

Clinical trial NCT04412486 · COMPLETED

Trial details

NCT number
NCT04412486
Sponsor
Gailen D. Marshall Jr., MD PhD
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-06-01
Primary completion
2023-03-23
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.